Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 4169 - 4176 of 11613 results
FDA User Fees: Highlights from FDARA & Our Forecast for the Next Round
February 3, 2020| Blog| Viewpoint
Brexit Transition Period: Guidance from Information Commissioner’s Office
February 3, 2020| Blog| Viewpoint
What's New in 5G - February 2020
February 3, 2020| Blog| Viewpoint
Employers Confront the Coronavirus
February 3, 2020| News
Mintz Gains New Antitrust Co-Chair From Crowell & Moring
February 3, 2020| News
The Impact of AI
February 3, 2020| Article| Viewpoint
Apple’s Success Reversing Patent Cases May Dim CalTech’s Win
January 31, 2020| News
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.